Island Pharmaceuticals (ASX:ILA) Price-to-Tangible-Book : 9.71 (As of May. 25, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Island Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-25), Island Pharmaceuticals's share price is A$0.068. Island Pharmaceuticals's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.01. Hence, Island Pharmaceuticals's Price to Tangible Book Ratio of today is 9.71.

The historical rank and industry rank for Island Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

ASX:ILA' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.75 Med: 4 Max: 12.6
Current: 6.8

During the past 3 years, Island Pharmaceuticals's highest Price to Tangible Book Ratio was 12.60. The lowest was 2.75. And the median was 4.00.

ASX:ILA's Price-to-Tangible-Book is ranked worse than
80.59% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs ASX:ILA: 6.80

A closely related ratio is called PB Ratio. As of today, Island Pharmaceuticals's share price is A$0.068. Island Pharmaceuticals's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.01. Hence, Island Pharmaceuticals's P/B Ratio of today is 9.71.

Island Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Island Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Island Pharmaceuticals Price-to-Tangible-Book Chart

Island Pharmaceuticals Annual Data

Trend

Jun21

Jun22

Jun23

Price-to-Tangible-Book

3.56

2.75

4.41

Island Pharmaceuticals Semi-Annual Data
	Jun20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial			3.59	2.75	5.21	4.41	12.60

Competitive Comparison of Island Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Island Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Island Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Island Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Island Pharmaceuticals's Price-to-Tangible-Book falls into.

Island Pharmaceuticals Price-to-Tangible-Book Calculation

Island Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.068	/	0.007
	=	9.71

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Island Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Island Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Island Pharmaceuticals (ASX:ILA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Island Pharmaceuticals Ltd (ASX:ILA) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

697 Burke Road, Suite 201, Camberwell, VIC, AUS, 3124

Website

https://www.islandpharmaceuticals.com

Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections. Its lead asset ISLA-101 is a drug with a well-established safety profile, being repurposed for the prevention and treatment of dengue fever and another mosquito (or vector) borne diseases.

Island Pharmaceuticals (ASX:ILA) Headlines

No Headlines